<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02988193</url>
  </required_header>
  <id_info>
    <org_study_id>15-16045</org_study_id>
    <nct_id>NCT02988193</nct_id>
  </id_info>
  <brief_title>Piloting Healthcare Coordination in Hypertension</brief_title>
  <acronym>PRECISION</acronym>
  <official_title>Piloting Healthcare Coordination in Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Optima Integrated Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Optima Integrated Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PRECISION study investigates the possibility of integrating a clinical decision support&#xD;
      analytic intelligence into the clinical care flow at University of California San Francisco&#xD;
      Medical Center (UCSF MC). optima-for-blood pressure [optima4BP], our innovation, transforms&#xD;
      the episodic and reactive nature of uncontrolled HTN pharmacological treatment management&#xD;
      into a process that is continuous, proactive, and personalized.&#xD;
&#xD;
      In addition, the clinical adoption of this &quot;technology of the future&quot; will be investigated to&#xD;
      establish its feasibility in being embedded into the clinical care flow.&#xD;
&#xD;
      Today's hypertension (HTN) management paradigm often fails to align current patient health&#xD;
      status with the most effective medication treatment. Without surveillance and rapid-cycles&#xD;
      analysis of current patient health status and treatment efficacy, HTN management remains a&#xD;
      struggle. optima4BP addresses pharmacological intervention management by identifying the need&#xD;
      for a drug treatment change and recommending the most appropriate drug optimization.&#xD;
&#xD;
      The PRECISION study represent a pilot trial intended to address 2 critical design components&#xD;
      of optima4BP:&#xD;
&#xD;
        1. Can optima4BP interoperate with multiple IT platforms to collect and distribute data?&#xD;
&#xD;
        2. What is the treating physician confidence in using optima4BP?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Goal: Conduct a prospective randomized pilot clinical trial embedded within the care delivery&#xD;
      system at UCSF Medical Center (UCSF). It is intended to evaluate the efficacy of optima4BP in&#xD;
      improving care coordination for patients with uncontrolled hypertension (HTN). Although&#xD;
      optima4BP has been evaluated during patient-physician office visits, it has not been&#xD;
      evaluated for its efficacy to support treatment changes remotely, over time. PRECISION&#xD;
      investigates this aspect and its impact on stakeholders (physicians and patients). The&#xD;
      outcomes will set the stage for a scaled-up study of 300 patients at UCSF.&#xD;
&#xD;
      Study Design: The patients will be randomized to 2 arms (a) optima4BP surveillance and&#xD;
      treatment recommendation support (O4BP); (b) usual care (UC) - usual care seen appropriate by&#xD;
      the treating physician). NOTE: The original design prior to study initiation considered a 3&#xD;
      arms randomization which would also include: enhanced care (EC) representing a &quot;step up&quot; from&#xD;
      UC by providing the physician with raw remotely collected BP values sent on a monthly cycle.&#xD;
      However, this arm was abandoned at enrollment because patients in the UC arm were proactively&#xD;
      reaching out to their physicians with remotely collected BP values from the Qardio® device&#xD;
      therefore rendering the initially projected Extended Care arm unuseful.&#xD;
&#xD;
      Every 30 days, the collection of patient information will be followed by an arm-specific&#xD;
      action. For identified patients in need of a medication change, O4BP physicians will receive&#xD;
      a treatment change recommendation for review. UC physicians will not receive any information.&#xD;
      All patients will undergo at least 2 in-office visits, a baseline visit and an exit visit.&#xD;
      All patients will be asked to provide every 30 days the following information: (a) adherence&#xD;
      to current HTN treatment; and (b) experienced side-effects and severity. The communication&#xD;
      will be performed via e-mail between Health-e-Heart (HeH) automated system&#xD;
      (https://www.health-eheartstudy.org/) and the patient. HeH will automatically obtain BP&#xD;
      values from the remote monitors provided to each patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">February 28, 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The medication treatment intervention between arms differs in that the optima4BP arm uses an analytic intelligence algorithm to optimize drug treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Adoption of a Decision Support Artificial Intelligence</measure>
    <time_frame>6 months</time_frame>
    <description>Total number of participants that undergone a treatment change.&#xD;
This measure allows to evaluate the adoption of the optima4BP treatment recommendation based on the total number of patients that benefited from a treatment recommendation that was implemented by the treating physician.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>optima4BP Medication Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>optima4BP will provide a monthly medication optimization to the treating physician for review and subsequent implementation. The Treatment Recommendation will consist of:&#xD;
curated blood pressure (BP) and heart rate (HR) values reported by the patient through the use of home monitoring BP arm cuff;&#xD;
medication treatment recommendation;&#xD;
active link to access additional treatment analysis tools.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care Medication Management</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care management will follow medication treatment management according to the physician preference. The treating physician will not be provided with a medication optimization recommendation, nor with monthly curated BP and HR values.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optima4BP Medication Management</intervention_name>
    <description>A clinical reasoning expert system is used to determine the need for a medication treatment optimization. If a treatment optimization is needed, the expert system generates a recommendation that is sent to the treating physician.</description>
    <arm_group_label>optima4BP Medication Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  UCSF General Medicine patient&#xD;
&#xD;
          -  2 or more values on consecutive office visits within 12 months: systolic blood&#xD;
             pressure (SBP) &gt; 140 mmHg or diastolic blood pressure (DBP) &gt; 90&#xD;
&#xD;
          -  Therapy with at least 2 anti-hypertensive pharmacological classes at the time of the&#xD;
             last office visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Does not own a smartphone&#xD;
&#xD;
          -  Does not speak or read English&#xD;
&#xD;
          -  Planning to leave UCSF in the next year&#xD;
&#xD;
          -  Has a treating physician who refuses to enroll patients&#xD;
&#xD;
          -  Treating physician states that:&#xD;
&#xD;
        Patient cannot manage Qardio® arm blood pressure (BP) device (due to cognitive,&#xD;
        psychological, physical or other problems), or Patient is already at goal, or Should not&#xD;
        participate in the study for any other reason&#xD;
&#xD;
          -  Non-compliance with medical follow-up (frequent &quot;no shows&quot;)&#xD;
&#xD;
          -  Planned coronary revascularization in the next 6 months&#xD;
&#xD;
          -  Myocardial infarction, stroke, coronary revascularization, cardiac or aortic surgery&#xD;
             in the last 3 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriela Voskerician, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Optima Integrated Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Liviu Klein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Carlos</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2016</study_first_posted>
  <results_first_submitted>April 3, 2018</results_first_submitted>
  <results_first_submitted_qc>September 16, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 18, 2019</results_first_posted>
  <last_update_submitted>September 16, 2019</last_update_submitted>
  <last_update_submitted_qc>September 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clinical reasoning artificial intelligence</keyword>
  <keyword>poorly controlled hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>optima4BP Medication Optimization</title>
          <description>optima4BP will provide a monthly medication optimization to the treating physician for review and subsequent implementation. The Treatment Recommendation will consist of:&#xD;
curated blood pressure (BP) and heart rate (HR) values reported by the patient through the use of home monitoring BP arm cuff;&#xD;
medication treatment recommendation;&#xD;
active link to access additional analysis tools.&#xD;
optima4BP medication optimization: A clinical reasoning expert system is used to determine the need for a medication treatment optimization. If a treatment optimization is needed, the expert system generates a recommendation that is sent to the treating physician.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care Management</title>
          <description>Usual care management will follow medication treatment management according to the physician preference. The treating physician will not be provided with a medication optimization recommendation, nor with monthly curated BP and HR values.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>optima4BP Medication Management</title>
          <description>optima4BP will provide a monthly medication optimization to the treating physician for review and subsequent implementation. The Treatment Recommendation will consist of:&#xD;
curated blood pressure (BP) and heart rate (HR) values reported by the patient through the use of home monitoring BP arm cuff;&#xD;
medication treatment recommendation;&#xD;
active link to access additional analysis tools.&#xD;
optima4BP Medication Management: A clinical reasoning expert system is used to determine the need for a medication treatment optimization. If a treatment optimization is needed, the expert system generates a recommendation that is sent to the treating physician.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care Medication Management</title>
          <description>Usual Care Medication Management will follow medication treatment management according to the physician preference. The treating physician will not be provided with a medication optimization recommendation, nor with monthly curated BP and HR values.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71" spread="3"/>
                    <measurement group_id="B2" value="69" spread="5"/>
                    <measurement group_id="B3" value="70" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinical Adoption of a Decision Support Artificial Intelligence</title>
        <description>Total number of participants that undergone a treatment change.&#xD;
This measure allows to evaluate the adoption of the optima4BP treatment recommendation based on the total number of patients that benefited from a treatment recommendation that was implemented by the treating physician.</description>
        <time_frame>6 months</time_frame>
        <population>Clinical adoption based on physician acceptance of the treatment recommendation</population>
        <group_list>
          <group group_id="O1">
            <title>optima4BP Treatment Management</title>
            <description>optima4BP will provide a monthly medication optimization to the treating physician for review and subsequent implementation. The Treatment Recommendation will consist of:&#xD;
curated blood pressure (BP) and heart rate (HR) values reported by the patient through the use of home monitoring BP arm cuff;&#xD;
medication treatment recommendation;&#xD;
active link to access additional analysis tools.&#xD;
optima4BP medication optimization: A clinical reasoning expert system is used to determine the need for a medication treatment optimization. If a treatment optimization is needed, the expert system generates a recommendation that is sent to the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Treatment Management</title>
            <description>Usual care management will follow medication treatment management according to the physician preference. The treating physician will not be provided with a medication optimization recommendation, nor with monthly curated BP and HR values.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Adoption of a Decision Support Artificial Intelligence</title>
          <description>Total number of participants that undergone a treatment change.&#xD;
This measure allows to evaluate the adoption of the optima4BP treatment recommendation based on the total number of patients that benefited from a treatment recommendation that was implemented by the treating physician.</description>
          <population>Clinical adoption based on physician acceptance of the treatment recommendation</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected during the entire course of the 6 months study.</time_frame>
      <desc>The definition of adverse event does not differ from clinicaltrials.gov Definition.</desc>
      <group_list>
        <group group_id="E1">
          <title>optima4BP Treatment Management</title>
          <description>optima4BP will provide a monthly medication optimization to the treating physician for review and subsequent implementation. The Treatment Recommendation will consist of:&#xD;
curated blood pressure (BP) and heart rate (HR) values reported by the patient through the use of home monitoring BP arm cuff;&#xD;
medication treatment recommendation;&#xD;
active link to access additional analysis tools.&#xD;
optima4BP medication optimization: A clinical reasoning expert system is used to determine the need for a medication treatment optimization. If a treatment optimization is needed, the expert system generates a recommendation that is sent to the treating physician.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care Treatment Management</title>
          <description>Usual care management will follow medication treatment management according to the physician preference. The treating physician will not be provided with a medication optimization recommendation, nor with monthly curated BP and HR values.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gabriela Voskerician</name_or_title>
      <organization>Optima Integrated Health</organization>
      <phone>6502233588</phone>
      <email>gxv4@case.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

